Abstract
Patients with active Systemic Lupus Erythematosus (SLE) experience a large variation of symptoms and manifestations. The symptoms and manifestations of SLE impact the patients’ health-related quality of life (HRQoL). Many of the patients’ SLE symptoms are not always adequately captured by objective clinical outcome measures or laboratory assessments alone. Therefore in addition to well-established clinical outcome measures used in clinical practice, the patient perspective should be captured through patient reported outcome measures (PROMs). Key concepts/domains derived from a recently developed conceptual model published by Holloway et al. (Qual Life Outcomes. 2014;12:116) are the basis for the recommendations of PROMs. Recommendations for PROMs to apply in clinical practice are based on the face and content validity as well as psychometric properties of each of the PROMs. In the conceptual model, fatigue, pain, and emotional well-being/depression were identified as key domains impacting the lives of patients with SLE. Appropriate PROMs to use in clinical practice capturing the key domains are the Functional Assessment of Chronic Illness Therapy—Fatigue scale (FACIT-Fatigue), Brief Pain Inventory (BPI-SF), and Hospital Anxiety and Depression Scale (HADS). In addition the generic HRQoL measure Short Form (36 item) Health Survey version 2 (SF-36v2) and the disease-specific HRQoL measure LupusQoL can be applied in clinical practice. It might be favorable in standard clinical practice to consider including one cohesive PROM for the assessment of patient reported key symptoms and impacts in SLE, however, further research and validation studies are needed. PROMs capturing key symptoms of SLE such as fatigue, pain, and HRQoL supplement objective clinical outcome measures and laboratory assessments providing clinicians with a valuable patient perspective on the impact of SLE.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J Rare Dis. 2006;1:6.
Jolly M, Pickard AS, Wilke C, Mikolaitis RA, Teh LS, McElhone K, Fogg L, Block J. Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Ann Rheum Dis. 2010;69:29–33.
Holloway L, Humphrey L, Heron L, Pilling C, Kitchen H, Højbjerre L, Strandberg-Larsen M, Bekker Hansen B. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance. Health Qual Life Outcomes. 2014;12:116.
Beckerman NL. Living with lupus: a qualitative report. Soc Work Health Care. 2011;50:330–43.
McElhone K, Abbott J, Gray J, Williams A, Teh LS. Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study. Lupus. 2010;19:1640–7.
Robinson J, Aguilar D, Schoenwetter M, Dubois R, Russak S, Ramsey-Goldman R, Navarra S, Hsu B, Revicki D, Cella D, Rapaport MH, Renahan K, Ress R, Wallace D, Weisman M. Impact of systemic lupus erythematosus on health, family, and work: the patient perspective. Arthritis Care Res. 2010;62:266–73.
Schneider M, Schmeding A, Carnarius H, Ager M, McWade V. Systemic lupus erythematosus (SLE): understanding the burden. Value Health. 2010;13:A470.
Yee CS, McElhone K, Teh LS, Gordon C. Assessment of disease activity and quality of life in systemic lupus erythematosus—new aspects. Best Pract Res Clin Rheumatol. 2009;23:457–67.
Aberer E. Epidemiologic, socioeconomic and psychosocial aspects in lupus erythematosus. Lupus. 2010;19:1118–24.
Strand V, Galateanu C, Pushparajah DS, Nikai E, Sayers J, Wood R, van Vollenhoven RF. Limitations of current treatments for systemic lupus erythematosus: a patient and physician survey. Lupus. 2013;22:819–26.
Pettersson S, Lovgren M, Eriksson LE, Moberg C, Svenungsson E, Gunnarsson I, Henriksson EW. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Scand J Rheumatol. 2012;41:383–90.
Gallop K, Nixon A, Swinburn P, Sterling KL, Naegeli AN, Silk ME. Development of a conceptual model of health-related quality of life for systemic lupus erythematosus (SLE) from the patients’ perspective. Lupus. 2012;21:934–43.
Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue. Measurement of fatigue in systemic lupus erythematosus: a systematic review. Arthritis Care Res. 2007;57:1348–57.
Cleanthous S, Tyagi M, Isenberg DA, Newman SP. What do we know about self-reported fatigue in systemic lupus erythematosus? Lupus. 2012;21:465–76.
Ramsey-Goldman R, Rothrock N. Fatigue in systemic lupus erythematosus and rheumatoid arthritis. PM R. 2010;2:384–92.
Mattsson M, Moller B, Stamm T, Gard G, Bostrom C. Uncertainty and opportunities in patients with established systemic Lupus Erythematosus: a qualitative study. Musculoskeletal Care. 2012;10:1–12.
Kosinski M, Gajria K, Fernandes AW, Cella D. Qualitative validation of the FACIT-fatigue scale in systemic lupus erythematosus. Lupus. 2013;22:422–30.
Danoff-Burg S, Friedberg F. Unmet needs of patients with systemic lupus erythematosus. Behav Med. 2009;35:5–13.
Yazdany J, Yelin E. Health-related quality of life and employment among persons with systemic Lupus Erythematosus. Rheum Dis Clin North Am. 2010;36:15–32.
Doward LC, McKenna SP, Whalley D, Tennant A, Griffiths B, Emery P, Veale DJ. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis. 2009;68:196–200.
Robinson M, Sheets CS, Currie LM. Systemic lupus erythematosus: a genetic review for advanced practice nurses. J Am Acad Nurse Pract. 2011;23:629–37.
Johnsson PM, Sandqvist G, Bengtsson A, Nived O. Hand function and performance of daily activities in systemic lupus erythematosus. Arthritis Rheum. 2008;59:1432–8.
Carls G, Li T, Panopalis P, Wang S, Mell AG, Gibson TB, Goetzel RZ. Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis. J Occup Environ Med. 2009;51:66–79.
Zhu TY, Tam LS, Li EK. The socioeconomic burden of systemic lupus erythematosus: state-of-the-art and prospects. Expert Rev Pharmacoecon Outcomes Res. 2012;12:53–69.
Zhu TY, Tam LS, Li EK. Cost-of-illness studies in systemic lupus erythematosus: a systematic review. Arthritis Care Res (Hoboken). 2011;63:751–60.
Yelin E, Katz P. Introduction to special section: cost and social and psychological impact of rheumatic diseases. Arthritis Rheum. 2008;59:457.
Zhu TY, Tam LS, Lee VWY, Lee KKC, Li EK. The impact of flare on disease costs of patients with systemic lupus erythematosus. Arthritis Rheum. 2009;61:1159–67.
Aghdassi E, Zhang W, St. Pierre Y, Clarke AE, Morrison S, Peeva V, Landolt-Marticorena C, Su J, Reich H, Scholey J, Herzenberg A, Pope JE, Peschken C, Lunnet Canios I, Wither JE, Fortin PR. Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis. J Rheumatol. 2011;38:658–66.
Strand V, Chu AD. Measuring outcomes in systemic lupus erythematosus clinical trials. Expert Rev Pharmacoecon Outcomes Res. 2011;11:455–68.
Furie R, Petri MA, Strand V, Gladman DD, Zhong ZJ, Freimuth WW. Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials. Lupus Sci Med. 2014;1, e000031.
Lai JS, Beaumont JL, Ogale S, Brunetta P, Cella D. Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial. J Rheumatol. 2011;38:672–9.
Chandran V, Bhella S, Schentag C, Gladman DD. Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann Rheum Dis. 2007;66:936–9.
Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005;32:811–9.
Ozel F, Argon G. The effects of fatigue and pain on daily life activities in systemic lupus erythematosus. European J Internal Med. 2011;22:S70.
Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1(3):277–99.
Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30(2):191–7.
Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23(2):129–38.
Cleeland CS. The brief pain inventory: user guide. 2009. 63 p. http://www.mdanderson.org/education-and-research/departments-programs-andlabs/departments-and-divisions/symptom-research/symptom-assessmenttools/BPI_UserGuide.pdf.
Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330(9):592–6.
Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labelling claims. Silver Spring, MD: Food and Drug Administration; 2009.
Atkinson TM, Rosenfeld BD, Sit L, Mendoza TR, Fruscione M, Lavene D, Shaw M, Li Y, Hay J, Cleeland CS, Scher HI, Breitbart WS, Basch E. Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI). J Pain Symptom Manage. 2011;41(3):558–65.
Daut RL, Cleeland CS, Flannery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983;17(2):197–210.
Naegeli AN, Tomaszewski EL, Al Sawah S. Psychometric validation of the Brief Pain Inventory-Short Form in patients with systemic lupus erythematosus in the United States. Lupus. 2015;24:1377–83.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2002;1:29.
Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-A review of validation data and clinical results. J Psychosom Res. 1997;42:17–41.
Garris CP, Oglesby AK. Assessment of health care resource utilization by level of flare severity in patients with systemic lupus erythematosus (SLE) in the managed care setting. J Manag Care Pharm. 2011;17:552.
QualityMetric Inc. User’s manual for the SF-36v2 health survey. 3rd ed. 2011. http://www.qualitymetric.com/WhatWeDo/ManualsUserGuides/UsersManualfortheSF36v2HealthSurvey/tabid/328/Default.aspx.
Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–4.
Beaumont JLLJ, Cella D, Brunetta P, Ogale S. Validation of the SF-36 in patients with systemic lupus erythematosus (SLE). Arthritis Rheum. 2009;60:296.
Busija L, Pausenberger E, Haines TP, Haymes S, Buchbinder R, Osborne RH. Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQOL) [abstract]. Arthritis Care Res. 2011;63:S383–412.
McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, Gordon C, Peers K, Isenberg D, Ferenkeh-Koroma A, Griffiths B, Akil M, Maddison P, Teh L-S. Development and validation of a disease-specific health-related quality of life measure, the LupusQoL, for adults with systemic lupus erythematosus. Arthritis Care Res. 2007;57:972–9.
Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.
Food and Drug Administration. Guidance for industry: systemic lupus erythematosus—developing medical products for treatment. 2010. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072063.pdf.
European Medicines Agency. Guideline on clinical investigation of medicinal products for the treatment of systemic lupus erythematosus, cutaneous lupus and lupus nephritis (draft). 2013. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/03/WC500139615.pdf.
El Miedany Y, El Gaafary M, El Yassaki A, Ahmed I, Youssef S, Hegazi MO, Palmer D. Incorporating patient reported outcome measures in clinical practice: development and validation of a PROMs questionnaire for SLE. Ann Rheum Dis. 2013;72 Suppl 3:484.
Jolly M, Garris CP, Mikolaitis RA, Jhingran PM, Dennis G, Wallace DJ, Clarke A, Dooley MA, Parke A, Strand V, Alárcon GS, Kosinski M. Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2014;66(10):1542–50.
Ruperto N, Hanrahan LM, Alarcon GS, Belmont HM, Brey RL, Brunetta P, Buyon JP, Costner MI, Cronin ME, Dooley MA, Filocamo G, Fiorentino D, Fortin PR, Franks Jr AG, Gilkeson G, Ginzler E, Gordon C, Grossman J, Hahn B, Isenberg DA, Kalunian KC, Petri M, Sammaritano L, Sánchez-Guerrero J, Sontheimer RD, Strand V, Urowitz M, von Feldt JM, Werth VP, Merrill JT. International consensus for a definition of disease flare in lupus. Lupus. 2011;20:453–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendices
Appendix 1: FACIT-Fatigue is presented with permission from the copyright holder. Potential users
Potential users should go to http://www.facit.org/FACITOrg and contact copyright holder for permission before using FACIT-Fatigue in studies and clinical practice.
FACIT Fatigue Scale (Version 4)
Below is a list of statements that other people with your illness have said are important. Please circle or mark one number per line to indicate your response as it applies to the past 7 days.
Not at all | A little bit | Some-what | Quite a bit | Very much | ||
HI7 | I feel fatigued | 0 | 1 | 2 | 3 | 4 |
HI12 | I feel weak all over | 0 | 1 | 2 | 3 | 4 |
An1 | I feel listless (washed out) | 0 | 1 | 2 | 3 | 4 |
An2 | I feel tired | 0 | 1 | 2 | 3 | 4 |
An3 | I have trouble starting things because I am tired | 0 | 1 | 2 | 3 | 4 |
An4 | I have trouble finishing things because I am tired | 0 | 1 | 2 | 3 | 4 |
An5 | I have energy | 0 | 1 | 2 | 3 | 4 |
An7 | I am able to do my usual activities | 0 | 1 | 2 | 3 | 4 |
An8 | I need to sleep during the day | 0 | 1 | 2 | 3 | 4 |
An12 | I am too tired to eat | 0 | 1 | 2 | 3 | 4 |
An14 | I need help doing my usual activities | 0 | 1 | 2 | 3 | 4 |
An15 | I am frustrated by being too tired to do the things I want to do | 0 | 1 | 2 | 3 | 4 |
An16 | I have to limit my social activity because I am tired | 0 | 1 | 2 | 3 | 4 |
Appendix 2: Brief Pain Inventory—Short Form
BPI-SF is presented with permission from the copyright holder. Potential users should go to www.mdanderson.org/departments/prg and contact copyright holder for permission before using BPI-SF in studies and clinical practice.
Appendix 3: LupusQoL
LupusQoL is presented with permission from the copyright holders. Anyone running a commercially funded study must obtain a license for the LupusQoL and pay the license fee. Use is free for noncommercially funded studies but copyright holders requires that researchers contact the licensors for permission before using to ensure that researchers use the professionally developed and validated translations only.
Potential users should go to www.lupusqol.com for more information on using LupusQoL in studies and clinical practice.
Appendix 4: Multidimensional Questionnaire for Patient Reported Outcome Measures—SLE
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hansen, B.B., Højbjerre, L. (2016). PROMs for Systemic Lupus Erythematosus. In: El Miedany, Y. (eds) Patient Reported Outcome Measures in Rheumatic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-32851-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-32851-5_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32849-2
Online ISBN: 978-3-319-32851-5
eBook Packages: MedicineMedicine (R0)